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Abstract 
Background and Aims 
Ano-genital granulomatosis is a rare chronic granulomatous condition of the skin that causes 
lymphoedema of the external genitalia. There is a reported association with Crohn's disease. 
Mechanisms of disease, and optimal methods of treatment are poorly understood. 
Methods  
A retrospective case note review of 25 male patients with ano-genital granulomatosis presenting 
with genital lymphoedema  was performed to determine the clinical and histopathological features 
of this condition and its relationship to intestinal Crohn's disease. 
Results 
A combination of penile and scrotal oedema was reported at presentation in 80% of patients. 40% of 
patients had associated intestinal Crohn's disease. The average time from symptom onset to 
diagnosis was 52.7 months. Half of cutaneous biopsies contained non-caseating granulomas and 14% 
contained intra-lymphatic granulomas. 72% of patients responded to oral steroids initially but 
recurrence was common. Complete or partial response was achieved in 60% of patients treated with 
azathioprine. Three of 6 patients responded to anti-TNF therapy. A small proportion of patients 
required circumcision or de-bulking surgery for more debilitating disease. 
Conclusions 
Ano-genital granulomatosis is a rare condition that presents with genital lymphoedema and there is 
frequently a protracted delay in diagnosis. There is a very strong association with intestinal Crohn's 
disease. Genital lymphoedema associated with gastrointestinal symptoms should prompt careful 
evaluation to exclude both ano-genital granulomatosis and Crohn's disease. 
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Introduction 
Ano-genital granulomatosis (AGG) is a rare idiopathic chronic inflammatory condition that presents 
with progressive and persistent genital and peri-genital oedema, and usually non-caseating 
granuloma are revealed on skin biopsy.1 Although the condition was first formally described in the 
1970s,2  the medical literature has largely been limited  to case reports and small case series.1,3,4,5 
Reports have indicated a possible overlap with Crohn's disease (CD).6,7,8,9  
 The condition usually manifests as chronic penile, scrotal, vulval or perianal oedema but may affect 
the more extensive peri-genital area including the mons pubis, buttocks and natal cleft.   Episodes of 
secondary cellulitis occur frequently as with many other forms of lymphoedema.10 Histology from 
affected skin typically demonstrates the presence of non-caseating granulomas and a chronic 
inflammatory infiltrate, although granulomas may be sparse and easily missed. The exact underlying 
aetiology is not clearly understood, but a variety of both infective and inflammatory conditions have 
previously been associated with this condition including sarcoid, Behcet's, Wegener's 
granulomatosis, tuberculosis and syphilis.1 
Where AGG and CD co-exist genital lymphoedema may result from the direct extension of ano-rectal 
CD into the affected skin, but equally can occur without contiguity between skin and gastrointestinal 
tract.11 Impaired lymphatic drainage has previously been implicated in the pathogenesis of CD.12 
Similar histopathological changes that occur in AGG have been described in intestinal Crohn's 
disease, which may explain the observed overlap seen between these conditions.13 
Little is known about the optimal management of AGG, but the use of antibiotics, corticosteroids, 
and Tumour Necrosis Factor inhibitors (aTNF) in the management of AGG have all been described in 
case reports. 14,11,15,16  A recent case series has reported the clinical features of vulval lymphoedema  
in 22 females with and without CD.16 We therefore aimed to characterise the clinical features, 
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histological findings, response to treatment and overlap with CD in a cohort of 25 male patients with 
a confirmed diagnosis of AGG presenting with genital swelling to a national lymphoedema unit. 
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Methods 
This was a retrospective descriptive case series. Patients with genital  lymphoedema and a suspected 
diagnosis of AGG were referred to our centre where they were reviewed in the joint 
gastroenterology and lymphoedema clinic. Initial evaluation included a full clinical history, a detailed 
physical examination, and assessment of the pattern of genital (and peri-genital) lymphoedema. 
After acquiring full patient consent, digital photographic images were made of the extent of genital 
oedema, as a reference to assess treatment response. Samples for histological diagnosis were taken 
at the first clinic assessment, usually with a punch biopsy under local anaesthetic.  Histology was 
reported by two specialist histopathologists. All potential cases of the condition were discussed by 
the Gastroenterology-Lymphoedema team at a multi-disciplinary team meeting and agreed cases of 
AGG were collated in a database. 
Clinical-pathological data was collected retrospectively (CA and RM) for this study. The clinical notes, 
letters, electronic records and histology were retrospectively reviewed for each confirmed case of 
AGG. Co-existent medical conditions were ascertained from historical clinical records and/or 
confirmation with the patient.  Details of medical and surgical treatments were obtained by case 
note review.  
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Results 
Demographics 
We identified 25 male patients with a confirmed diagnosis of AGG from the database between 
August 2006 and October 2015 (Table 1). Mean follow-up was 24.4 months (range 1-81 months). 
Twenty-four patients were Caucasian (one Asian). Mean age at diagnosis was 32.2 years (range 7-66 
years). The mean number of months between self-reported symptom onset and formal diagnosis 
was 52.7 months (range 6-264 months). The hospital specialties that the patients were initially 
referred to were: Dermatology (56%), Urology (32%) and others (12% - including genitourinary 
medicine, paediatrics and plastic surgery). 
Clinical Presentation 
The commonest anatomical site for oedema was the penis (92% of patients), and scrotum (80%). 
Figure 1 demonstrates the characteristic lymphoedematous appearance of the external male 
genitalia in two patients suffering from AGG, one of whom also had intestinal CD. The combination 
of penile and scrotal involvement was seen in 80% of patients. Table 2 shows the respective areas of 
anatomical involvement in AGG patients with and without CD. Ulceration and fissuring was not a 
common presenting feature in these patients. 
 All patients described a chronic progressive disease pattern characterised by relapsing and remitting 
periods of increased genital lymphoedema, interspersed with periods of erythema, resulting from 
secondary cellulitis. Patients also frequently described problems with urinary flow and difficulties 
with sexual intercourse.  
Co-morbidities 
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13 patients (52%) had other medical diagnoses at the time of AGG diagnosis. Additional co-
morbidities are reported on Table 1 (and additional table 1 in appendix), although notably, these 
included ulcerative colitis (n=1), psoriasis (n=3) and orofacial granulomatosis (n=4). 
Gastrointestinal symptoms and associated Crohn's disease 
44% of patients reported concurrent gastroenterological symptoms at presentation. Symptoms 
described included diarrhoea (73%) and abdominal pain or discomfort (36%). In total, following 
investigation, 10 patients (40%) were found to have clinical, endoscopic and radiological findings 
consistent with Crohn's disease (CD). Five CD patients (50%) had the disease diagnosed prior to their 
AGG diagnosis. Seven patients with Crohn's had available colonoscopy reports: normal (n=1), colonic 
disease (n=3), terminal ileal disease(n=2), and terminal ileal plus rectal penetrating disease (n=1).  
Histology 
Full histology was available for 22 patients (88%). Two patients had biopsy and histology assessed at 
the referring hospital and found to be consistent with AGG. One patient refused genital biopsy, but it 
was agreed that his clinical presentation was consistent with a diagnosis of AGG. Table 3 categorises 
the frequency of the histological findings associated with AGG. All samples contained a lymphocytic 
predominant chronic inflammatory infiltrate. 57% of the biopsies contained identifiable non-
caseating granulomas, and 14% contained intra-lymphatic granulomas. Figure 2 demonstrates some 
of the pertinent histological findings associated with AGG. 
 Management and treatment response 
The medical treatments and the proportion of patients reporting response in AGG symptoms is 
summarised in Figure 3. 
Supportive therapy - all patients were referred to lymphoedema clinical nurse specialists and 
received compression garments and instructions on penile bandaging in cases of severe penile 
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lymphoedema, although standard lymphoedema treatment had limited efficacy without addressing 
the underlying inflammatory component of the disease process.  
Oral antibiotics -  antibacterial agents were used in 84% of patients. They were predominantly 
prescribed as long term prophylaxis (1-6 months) to prevent episodes of secondary cellulitis. 76% of 
patients reported an improvement in their AGG symptoms with antibiotic use. Prophylactic 
antibiotics used included; doxycycline 100mg OD,  co-trimoxazole 960mg OD, co-trimoxazole 480mg 
BD, co-amoxiclav 375mg TDS, clindamycin 250mg OD and trimethoprim 200mg OD. 
Oral corticosteroids - oral steroid therapy, were used in 72% of the patients (usually in combination 
with antibiotics), with 72% of patients treated showing initial improvement in lymphoedema, 
although relapse on tapering the doses was common. Prescription data was available for 11 patients 
receiving 12 reducing courses of prednisolone. Mean starting prednisolone dose was 34.1mg (range 
20-50mg). Dose reduction intervals were generally between 7-14 days per drop in dosage.  
Immunomodulators - Azathioprine (AZA) was used in 60% of the patients. In total, 60% made a 
complete or partial response to treatment, as demonstrated by an improvement in swelling. 
Complete prescribing data was available for 11 patients. Mean dose of AZA was 131.4mg/day (range 
50-200mg/day) with a mean duration of treatment 18.7 months (range 5-46 months). 7 of the 10 
AGG patients with Crohn's were treated with AZA. From the 15 non-CD AGG patients, 8 were treated 
with azathioprine, of which 87% reported improvement on symptoms. Mycophenolate mofetil (MM) 
was used in one non-CD AGG patient (1g BD, 42 months) whose AGG symptoms improved with this 
medication.  One AGG patient with CD had to stop MM due to side effects. 
Tumour Necrosis Factor Inhibitors (aTNF) - aTNF therapy was used in 6 AGG patients, all of whom 
had a co-diagnosis of CD. Standard induction regimes were used for both infliximab and 
adalimumab. Four patients were treated with infliximab, and 2 with adalimumab. A total of 3 
patients gained benefit with reduction in genital lymphoedema. 
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Surgical therapies 
Although surgery is not considered curative for AGG, it can be employed to reduce the volume of 
lymphoedema resulting from the underlying inflammatory changes. Indications for surgery included; 
failure of medical treatment, difficulties with micturation, difficulties with sexual intercourse, and 
cosmetic reasons. Two main surgical techniques were used; circumcision (n=6) of which 83% 
reported improvement in symptomology; or de-bulking surgery (n=4), with all patients reporting 
initial  improvement. The preferred surgical de-bulking procedure involves excision of lymphoedema 
tissue followed by split skin grafting and/or excision of excess scrotal tissue with primary closure. 
The mean time to surgery from AGG diagnosis was 13 months. No immediate post surgical  
complications were reported in the 4 patients who underwent de-bulking. By approximately one to 
two years post de-bulking surgery, all four patients had minimal recurrence of penile oedema. One 
patient had redeveloped severe penile oedema by four years post surgery, and was being 
considered for a further de-bulking procedure. 
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Discussion 
Key findings 
To our knowledge, this is the largest study of male patients with AGG, 40% of whom were found to 
have intestinal CD. The majority of patients initially presented with chronic penile and scrotal 
oedema. There was often a protracted delay between first reported symptoms and formal diagnosis,  
approaching a mean of 5 years. Skin biopsy from affected areas revealed non-caseating granulomas 
in more than half of patients, and 14% had intra-lymphatic granulomas.  All 25 patients reported a 
chronic progressive disease pattern characterised by recurring episodes of genital oedema with or 
without a secondary cellulitis. Almost three quarters of patients experienced short-term 
improvement with oral corticosteroid therapy, but most needed second line treatment in the form 
of immunomodulators, or aTNF therapy to achieve a sustained response. 
Findings in relationship to other studies 
40% of our cohort had both AGG and CD in keeping with the findings of previous case reports. In a 
review of previously reported cases of AGG, 36% of patients had concomitant CD.1 It is important to 
recognise that AGG may precede the diagnosis of CD by many years,17 but equally can manifest 
following confirmation of CD. In our series, half of patients were diagnosed with CD following their 
AGG diagnosis, and in this respect resembles oro-facial granulomatosis (OFG).18 
The considerable period between self-reported first symptoms and formal diagnosis seen in our 
cohort is similar to that reported in a case series of female patients with vulval Crohn's.16 This 
presumably relates to clinicians unfamiliarity with the condition, resulting in misdiagnosis and 
inappropriate specialist referral. Patient embarrassment may also be a contributing factor to delayed 
presentation.19 
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Our study is confined to male patients with confirmed AGG, but we do not feel this is a distinct 
clinical entity exclusive to males as we have also managed female patients with this condition 
presenting with vulval oedema very much as described previously by Laftah et al which this research 
group have defined as “vulval Crohn’s disease”.16 Furthermore, in a summary of historical individual 
case reports and series, about 40% of patients with AGG were male.1 
The presence of non-caseating granulomas is a common finding in patients with AGG and was seen 
in more than half of our cohort. The occurrence of intra-lymphatic granulomas may represent a 
potential mechanism through which lymphatic drainage is impeded leading to the genital 
lymphoedema and subsequent inflammation.20 We found evidence to support this disease 
mechanism, with 14% and 52% of our biopsies showing intra-lymphatic granulomas and lymphatic 
dilatation respectively. Intra-lymphatic granulomas and lymphangiectasia have also been described 
in OFG.21 OFG is a rare clinical entity manifest by lymphoedema of the face and oral cavity and 
shares many of the histological characteristics of AGG.22 OFG is also reported to overlap with 
intestinal CD in 20-40% of cases.18,23 Notably in our series, four patients had OFG, 2 of whom had a 
triad of AGG,OFG and CD.  
Impairment of lymphatic drainage in intestinal CD has also been linked to granulomatous 
obstruction of lymphatic flow, lymphangiectasia and lymphangitis.12,13 In one study, 46% of 
granuloma found within biopsies taken from patients with intestinal CD were related to or in close 
proximity to lymphatic vessels.24 These observations possibly point to a common pathway between 
the two clinical entities. Certainly, a role for lymphatic insufficiency in the aetio-pathogenesis of CD 
has previously been proposed.13,25  
The nomenclature is confusing and it has been argued by some authors that AGG is indistinguishable 
from cutaneous metastatic CD.15 However, we propose that AGG and MCD are two separate 
presentations of cutaneous granulomatous inflammation as a result of CD. Metastatic Crohn’s 
disease (MCD) is a rare cutaneous granulomatous disorder where patients present with pruritic 
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erythematous plaques or nodules that are non-contiguous with the gastrointestinal tract, and 
separated from it by normal skin.  MCD may affect the face, trunk and limbs, but may also affect 
genital skin.26 Histological analysis of these lesions confirms the presence of a non-caseating 
granulomatous inflammatory infiltrate.27 
AGG may appear similar to MCD to some readers because of the reported presence of granuloma 
within the skin. We hypothesise that AGG is in fact a separate entity based on three factors. Firstly, 
the defining feature of AGG is the presence of swelling and lympoedema, which is not  a feature of 
MCD. Secondly, AGG only affects the ano-genital region, whereas MCD frequently affects non-
genital skin. Finally, over 98% of patients with MCD have, or will subsequently develop a co-
diagnosis of CD,28 whereas co-diagnosis in AGG is only approximately 40%. 
Studies addressing optimal management of AGG are lacking. The use of antibiotics has been 
previously described in the management of AGG with mixed success.11,14,16 In this case series, 
antibiotics were used frequently where secondary cellulitis was suspected, and as prophylaxis 
against further episodes. Infection, particularly cellulitis, is common in patients with AGG probably 
as a direct result of impaired immune surveillance within regions of damaged lymphatic drainage.10 
Antibiotics are likely to be of benefit in acute flares where a secondary cellulitis may complicate the 
underlying granulomatous inflammation. Low dose antibiotic prophylaxis may also be indicated, 
although their role in preventing disease progression is unknown, and it is plausible that recurrent 
cellulitis may cause irreversible lymphatic damage. 
Oral corticosteroid therapy provided short-term benefit in our patients, often with initial 
improvement in oedema. Steroid treatment is usually ineffective in primary lymphoedema as the 
impaired lymphatic drainage occurs as a result of a genetically predetermined weakness within the 
lymphatic channels. However, their action on the inflammatory component of AGG may explain their 
efficacy in this condition. The efficacy of corticosteroids in the long-term is limited since we have 
observed oedema frequently recurs on cessation of treatment. 
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Immuno-modulators such as azathioprine (AZA) may have a role in the long-term treatment of AGG. 
They have established efficacy in the treatment of intestinal CD and are also used frequently in 
management of OFG.23 In our series, clinical improvement was found in both patients with and 
without associated CD. Two thirds of our cohort treated with AZA had symptomatic improvement. 
Laftah et al reported  similar response rates in a cohort of female patients with vulval CD.16 
Our experience with aTNF therapy was limited to 6 patients, all of whom had CD, and half of which 
reported symptomatic improvement in AGG symptoms. Previous case reports have indicated 
response in both patients with AGG, with and without intestinal CD.5,16 
Conclusion 
Ano-genital granulomatosis is a rare condition and usually presents with penile and scrotal 
lymphoedema in males.  Unless the clinician is vigilant, there may be a protracted delay in diagnosis. 
In this largest case series, we have confirmed a strong association with Crohn's disease.  Genital 
lymphoedema in association with gastrointestinal symptoms should prompt careful evaluation to 
exclude AGG and intestinal Crohn's disease. A variety of treatment options for AGG exist and many 
of the agents used in the management of Crohn's also appear effective in AGG. However, further 
studies are required to define optimal treatment in this condition. 
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Legends 
Table 1 legend 
a co-morbidities included: orofacial granulomatosis (n=4), psoriasis (n=3), ischaemic heart disease, 
hypertension, type 2 diabetes, ulcerative colitis, hydradenitis suppurativa, connective tissue disease, 
Coeliac's disease, Hirschsprung's disease, hypospadias, primary sclerosing cholangistis (n=1). aTNF - 
anti-tumour necrosis factor. Full details submitted as an appendix table. 
 
Table 2 legend 
No significant differences observed between groups. CD - Crohn's disease, AGG - ano-genital 
granulomatosis 
 
Figure 1 legend 
 A - typical appearance of penile oedema in a male patient presenting with AGG. The oedema affects 
the foreskin and shaft tissue and can cause difficulties with micturation and erection. In this patient, 
no features of intestinal CD were found on small bowel MRI, endoscopy or colonoscopy. B - AGG in 
an adolescent presenting with penile oedema before the onset of small and large bowel CD. Note 
the erythematous penile shaft swelling, and the subtle lymphoedema of the scrotum 
Figure 2 legend 
 - skin biopsy showing a well formed non-necrotising granuloma in the dermis associated 
with a mild lymphocytic infiltrate. The granuloma is immediately adjacent to a vascular 
channel. B - a non-necrotising granuloma directly adjacent to a lymphatic vessel. An 
aggregate of histiocytes and lymphocytes is present within the dilated lumen of the vessel 
Manuscript Doi : 10.1093/ecco-jcc/jjw173
 by guest on Septem
ber 30, 2016
http://ecco-jcc.oxfordjournals.org/
D
ow
nloaded from
 
Ac
ce
pt
ed
 M
an
us
cr
ipt
21 
 
 
(intralymphatic histiocytosis). C - a loosely formed non-necrotising granuloma next to a 
lymphatic channel. D - an aggregate of histiocytes within the dilated lumen of a lymphatic 
channel. 
 
Figure 3 legend 
Figure 3: histogram showing numbers of patients exposed to various treatments, and proportion of 
patients that did/didn't experience improvement. Numbers shown in columns. Abx - antibiotics, po 
C/S - oral corticosteroid, Aza - azathioprine, Myc - mycophenolate, aTNF - anti tumour necrosis 
factor inhibitors, Sx - symptoms 
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Table 1: Summary  of demographics, clinical features and treatments received by 25 male patients 
with AGG 
Clinical Feature AGG patients 
n = 25 
Mean age at diagnosis 32.2 years 
(range 7-66) 
Mean time from symptom onset to 
diagnosis 
52.7 months 
(range 6-264) 
Other co-morbidities 
a 
13 (52%) 
Co-diagnosis of Crohn's disease 10 (40%) 
Treatments received 
          Antibiotics 
          Oral steroids 
          Azathioprine 
          Mycophenolate 
          aTNF inhibitors 
 
21 (84%) 
18 (72%) 
15 (60%) 
2 (8%) 
6 (24%) 
Requirement for circumcision 6 (24%) 
Requirement for de-bulking surgery 4 (16%) 
 
 
 
 
 
 
a 
co-morbidities included: orofacial granulomatosis (n=4), psoriasis (n=3), ischaemic heart disease, 
hypertension, type 2 diabetes, ulcerative colitis, hydradenitis suppurativa, connective tissue disease, 
Coeliac's disease, Hirschsprung's disease, hypospadias, primary sclerosing cholangistis (n=1). aTNF - anti-
tumour necrosis factor. Full details submitted as an appendix table. 
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Table 2: proportion and distribution of anatomy affected in male patients diagnosed with AGG both 
with and without Crohn's disease 
 
Anatomy affected 
by lymphoedema 
AGG no CD  
n = 15  
AGG + CD 
n = 10 
All AGG 
n = 25 
Penis 87% 100% 92% 
Scrotum 80% 80% 80% 
Mons pubis 27% 30% 28% 
Buttock 27% 10% 20% 
Perineum 20% 20% 20% 
Peri-anal 13% 10% 12% 
Natal cleft 13% 10% 12% 
No significant differences observed between groups. CD - Crohn's disease, AGG - ano-genital granulomatosis 
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Table 3: Histological features from genital skin biopsies in male patients with ano-genital granulomatosis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Histological parameter 
 
% of patients 
n = 21 
Granulomas 57 
Multi-nucleate giant cells 24 
Chronic inflammatory infiltrate 100 
Lymphocytes 100 
Neutrophils 19 
Eosinophils 14 
Plasma Cells 57 
Histiocytes 43 
Mast cells 10 
Epidermal changes 67 
Oedema 52 
Dilated lymphatic vessels 52 
Intra-lymphatic granulomas 14 
Fibrosis 14 
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Figures 
Figure 1: classic presenting features of males with AGG 
 
A - typical appearance of penile oedema in a male patient presenting with AGG. The oedema affects 
the foreskin and shaft tissue and can cause difficulties with micturation and erection. In this patient, 
no features of intestinal CD were found on small bowel MRI, endoscopy or colonoscopy. B - AGG in 
an adolescent presenting with penile oedema before the onset of small and large bowel CD. Note 
the erythematous penile shaft swelling, and the subtle lymphoedema of the scrotum 
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Figure 2: Histological findings from skin biopsies of male patients with AGG 
 
A - skin biopsy showing a well formed non-necrotising granuloma in the dermis associated 
with a mild lymphocytic infiltrate. The granuloma is immediately adjacent to a vascular 
channel. B - a non-necrotising granuloma directly adjacent to a lymphatic vessel. An 
aggregate of histiocytes and lymphocytes is present within the dilated lumen of the vessel 
(intralymphatic histiocytosis). C - a loosely formed non-necrotising granuloma next to a 
lymphatic channel. D - an aggregate of histiocytes within the dilated lumen of a lymphatic 
channel. 
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Figure 3: histogram of medications prescribed and associated self-reported improvement in 
lymphoedema symptoms in 25 males with AGG 
 
Whole numbers shown in columns. Abx - antibiotics, po C/S - oral corticosteroid, Aza - azathioprine, Myc - mycophenolate, 
aTNF - anti tumour necrosis factor inhibitors, Sx - symptoms 
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